Substance Use Disorders
The clinical research activity is centered on opioid use disorder, with attention to treatment-resistant symptoms and relapse-related outcomes in individuals receiving maintenance therapy.
- Opioid use disorder
- Relapse prevention
- Maintenance treatment
Research interest in this area includes clinical strategies that support recovery in patients treated with methadone or buprenorphine/naloxone.
Psychiatric and Mood Symptoms
The funded work also addresses depressive symptom severity in the context of addiction treatment, reflecting a focus on the overlap between psychiatric symptoms and substance use.
- Depressive symptoms
- Mood disturbance
- Comorbid mental health symptoms
This area highlights interest in symptom relief alongside ongoing care for opioid dependence.
Ketamine-Based Therapeutics
Clinical interest extends to ketamine as an adjunctive therapeutic option, with emphasis on its role in modifying affective symptoms and supporting outcomes in opioid use disorder.
- Ketamine
- Adjunctive therapy
- Neuropsychiatric intervention
The research profile includes exploration of glutamatergic-targeted treatment approaches within addiction medicine.
